CLINICAL_TRIALS research · 2016-06-27

Clinical Trial Update: Glutamatergic Modulation of Cocaine-related Deficits [Phase 2]

Phase 2 clinical trial update exploring glutamatergic modulation for cocaine dependence; study completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: New York State Psychiatric Institute | Conditions: Cocaine Dependence | Phase 2 | Status: COMPLETED | Results posted: 2016-06-27